Robert Luther Huffines - 13 Dec 2022 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Reporting relationship: Director
Issuer ticker: SLDB
Reported as of: 13 Dec 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 15 Dec 2022, 17:13:42 UTC
Prior SEC filing: 09 Jun 2022
Next SEC filing: 29 Jan 2024
Source filing: View source filing
Reporting owner signature: /s/ by David Tyronne Howton as attorney-in-fact for Robert Luther Huffines

Key filing fact

Robert Luther Huffines filed Form 4 for Solid Biosciences Inc. (SLDB) on 15 Dec 2022.

Key facts

This page summarizes Robert Luther Huffines's Form 4 filing for Solid Biosciences Inc. (SLDB).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 15 Dec 2022, 17:13.

Change

Previous filing in this sequence was filed on 09 Jun 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SLDB transaction Derivative

Director Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +9,650
Change %
Price: $0.000000
Shares after: 9,650
Date: 13 Dec 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 9,650
Exercise price: $6.47
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This option was granted on December 13, 2022 and vests in full on the one-year anniversary of the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.

SEC remarks

Exhibit Index: 24.1 Power of Attorney